JBJS - 2026-09-30 - Journal Article
Global Projection of Revision Total Hip and Knee Arthroplasty Through 2060: A 17-Country Analysis Using Worldwide Registry Data.
Adolf J, Karlıdağ T, Citak M
Topics
Key Takeaway
Across 17 registry-equipped countries, annual revision THA and TKA volumes are projected to increase 31% and 41% respectively by 2060, reaching 243,404 rTHAs and 267,456 rTKAs under the primary capped Poisson model.
Summary Depth
Choose how much analysis to show on this article page.
Summary
Using log-linear Poisson models with UN World Population Prospects 2024 denominators and national registry data, this study projected annual revision arthroplasty volumes through 2060 for 17 countries. The 2060 aggregate reached 243,404 rTHAs (+31%) and 267,456 rTKAs (+41%) under the primary model, with the US and China driving absolute growth while Germany, UK, Sweden plateaued and Japan declined. Four sensitivity analyses bracketed combined 2060 volumes between ~461,000 and ~511,000 procedures.
Key Limitation
The model cannot incorporate future changes in primary implant survivorship, bearing surface innovation, or infection-prevention efficacy, meaning actual 2060 revision volumes could deviate substantially from projections in either direction.
Original Abstract
BACKGROUND
The expanding pool of primary hip and knee arthroplasty implants in situ will generate a growing burden of revision arthroplasty. Projections for several individual countries have been published, but heterogeneous methods and time horizons prevent direct aggregation. We used a uniform method to estimate annual revision total hip arthroplasty (rTHA) and revision total knee arthroplasty (rTKA) volumes through 2060 for 17 registry-equipped countries.
METHODS
Annual rTHA and rTKA counts were extracted from each country's most recent register annual report or registry-based publications. Adult (≥25 years) population denominators were taken from the UN World Population Prospects 2024 medium variant. For each country and procedure, we fitted a log-linear Poisson generalized linear model with the year as a covariate and ln(population) as an offset; each fitted trend was partially pooled across countries, bounded at ±2.0% per year, and damped over the projection horizon. Three sensitivity analyses (demographic-only, half-trend Poisson, logistic saturation) were also performed to bracket modeling uncertainty.
RESULTS
In 2024, the modeled 17-country aggregate was 185,921 rTHA and 189,689 rTKA procedures. Under the primary capped Poisson model, the 2060 aggregate reached 243,404 rTHAs and 267,456 rTKAs, corresponding to increases of 31% and 41%, respectively, relative to 2024. Country-level volume trajectories were heterogeneous: the United States and People's Republic of China drove most absolute growth, while Germany, the United Kingdom, and Sweden approached plateaus by mid-century and Japan was projected to have a decline. The 4 projection methods spanned 2060 combined volumes of ⁓461,000 (demographic-only) to ⁓511,000 (primary model) procedures.
CONCLUSIONS
Across 17 countries that perform most of the world's hip and knee arthroplasties, annual revision volumes are projected to grow by approximately one-third (36% in aggregate; 31% for rTHA and 41% for rTKA) by 2060 under the primary model. The United States and China account for the largest absolute growth; mature European systems flatten, and Japan declines. These projections have direct implications for revision-fellowship pipelines, perioperative infection-prevention programs, and registry infrastructure.
LEVEL OF EVIDENCE
Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.